biote Corp. Deferred Federal Income Tax Expense (Benefit)
biote Corp. (BTMD) reported Deferred Federal Income Tax Expense (Benefit) of $3.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-13
- biote Corp. deferred federal income tax expense (benefit) for fiscal 2025 was $3.93M.
- biote Corp. deferred federal income tax expense (benefit) for fiscal 2024 was -$2.52M, a 454.43% decline from fiscal 2023.
- biote Corp. deferred federal income tax expense (benefit) for fiscal 2023 was $711.00K.
- biote Corp. deferred federal income tax expense (benefit) for fiscal 2022 was -$714.00K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.93M 10-K · filed 2026-03-13 |
| 2024-12-31 | -$2.52M 10-K · filed 2026-03-13 |
| 2023-12-31 | $711.00K 10-K · filed 2025-03-14 |
| 2022-12-31 | -$714.00K 10-K · filed 2024-03-15 |
| 2021-12-31 | -$240.42K 10-K · filed 2022-04-07 |